Longevity Supplements: What Works, What’s Promising, What’s Hype

Aksana Labokha, PhD Aksana Labokha, PhD 25 May 2026 Last updated 19 June 2026 Medically reviewed
Longevity Supplements: What Works, What’s Promising, What’s Hype

Longevity supplements promise more healthy years — but the gap between marketing and evidence is wide. This guide sorts the field into three honest buckets: what works, what’s promising, and what’s overhyped. It is grounded in peer-reviewed aging research, written for general information rather than as a prescription, and points you to verified clinics that can test before you supplement. The goal is healthspan: years lived in good health, not just a longer pill list.

Key takeaways

  • No supplement is proven to extend human lifespan; the strongest evidence supports correcting genuine deficiencies, not chasing exotic compounds.
  • A short list of basics — vitamin D, omega-3s, and similar — has solid support for specific, common gaps.
  • NAD⁺ precursors and sirtuin activators are scientifically interesting but still preliminary in humans.
  • Most “anti-aging” marketing claims run far ahead of the human data; treat guarantees as a warning sign.
  • Test first, then supplement: a clinic can measure what you actually lack before you spend on what you might not need.

Longevity supplements: the short answer

No supplement has been shown to extend human lifespan. The honest position is narrower: a few well-studied nutrients can correct deficiencies that harm health, while most heavily marketed “longevity” compounds remain promising in the lab but unproven in people. The smartest first step is not a supplement at all — it is measuring what your body actually lacks, then targeting that gap.

That framing matters because supplements are a multi-billion-pound market built largely on extrapolation. Findings from cells, worms and mice are routinely sold as human benefits. Sorting hope from evidence is the whole point of this article.

The science behind it

Ageing is not one process but many interacting ones — and that is why no single pill can “fix” it. Researchers describe a set of interconnected biological drivers, often called the hallmarks of ageing, that span metabolism, mitochondrial function, inflammation and cellular repair (Cai et al., Sci China Life Sci 2022).

Most supplement hypotheses target one of these drivers. Some aim at cellular energy metabolism, which declines with age and is closely tied to heart and metabolic health (Xie et al., Signal Transduct Target Ther 2023). Others target NAD⁺, a coenzyme central to energy production and DNA repair that falls as we get older (Lautrup et al., Cell Metab 2019).

The key caveat is the translation gap. A compound that shifts a biomarker in a mouse may do nothing measurable for a person’s healthspan. Established nutrition science and early-stage longevity science deserve very different levels of confidence.

A second caveat is biological individuality. Ageing trajectories differ from person to person, so the same supplement can help one body and do nothing for another. This is why blanket recommendations are weak, and why measurement beats guesswork. The framework is useful for understanding why a supplement might work; it does not prove that a given product does.

Evidence-based strategies

The practical question is not “which supplement is best?” but “which has earned my trust, and for what?” Here is the field split into three buckets.

What works

The best-supported supplements are not exotic — they correct common, measurable deficiencies. Vitamin D is the clearest example: many adults, especially in northern climates, run low, and correcting a confirmed deficiency supports bone and immune health. Omega-3 fatty acids have reasonable evidence for cardiovascular and metabolic health, particularly in people with low dietary intake of oily fish.

The principle behind “what works” is replacement, not enhancement. These nutrients help when you are genuinely short of them. They are not shown to add years to a well-nourished person, and more is not better — some fat-soluble vitamins are harmful in excess.

This is also why testing comes first. A blood panel tells you whether you are deficient; a marketing page does not. Supplementing a level you already have wastes money and can carry risk.

Two other basics belong here for many people. Magnesium intake is often low, and a confirmed shortfall affects sleep, muscle and metabolic function. Vitamin B12 becomes harder to absorb with age, so older adults and those on plant-based diets are more likely to need it. Again, the logic is correction: confirm the gap, then fill it at a sensible dose.

What’s promising

Several compounds are scientifically credible but still early in human research. NAD⁺ precursors such as nicotinamide riboside and nicotinamide mononucleotide are the most prominent. They reliably raise NAD⁺ levels and show benefits in animal models of ageing and neurodegeneration (Lautrup et al., Cell Metab 2019). Whether that translates into longer, healthier human lives is an open research question, not a settled fact (Fang et al., Ageing Res Rev 2020).

Sirtuin-activating compounds, including resveratrol, sit in the same category. Sirtuins are enzymes involved in metabolic regulation and cellular stress responses, and slowing their age-related decline is a genuine research target (Grabowska et al., Biogerontology 2017). But human trials have been mixed, and effective, safe dosing in people is not established.

“Promising” means worth watching, not worth guaranteeing. If you choose to try these, do so with realistic expectations and ideally under medical supervision.

What’s overhyped

The hype bucket is the largest. It includes proprietary “longevity blends” with dozens of ingredients at token doses, compounds tested only in cells or short-lived animals, and any product claiming to reverse ageing or guarantee extra years. The marketing borrows the language of real science — hallmarks, telomeres, mitochondria — without the human evidence to back specific claims.

Be especially wary of three patterns. First, lifespan claims: no supplement has proven this in humans. Second, kitchen-sink formulas, where many under-dosed ingredients crowd a label to look impressive. Third, urgency and exclusivity, which sell scarcity rather than data.

A useful test: ask what the human evidence is for this product at this dose. If the answer points only to animal studies or a single ingredient in isolation, treat the claim as hype.

It is worth saying plainly that hype is not the same as fraud. Many overhyped supplements are harmless and may contain genuinely useful nutrients. The problem is the promise attached to them, not always the contents. Paying premium prices for guaranteed extra years buys marketing, not biology — and that money is often better spent on testing, food quality, sleep and exercise, which have far stronger evidence behind them.

How clinics can help

A good longevity clinic helps you supplement intelligently — by measuring first, then targeting real gaps. Rather than guessing from a marketing page, you get blood panels and biomarker testing that show what you actually lack, plus medical oversight to keep doses safe and avoid harmful interactions.

This matters most for the “promising” compounds, where dosing and safety in humans are still being worked out. A clinician can weigh your medications, conditions and goals, and separate an evidence-based correction from an experimental trial. You can compare verified clinics by location, services and ratings on our Longevity & Anti-Aging directory, and read our pillar guide on what a longevity clinic does for the bigger picture.

Frequently asked questions

What is the best supplement for longevity?
There is no single best longevity supplement, because none is proven to extend human lifespan. The most evidence-backed choices correct confirmed deficiencies — vitamin D and omega-3s are common examples. The genuinely “best” move is testing your biomarkers first, then targeting what you actually lack rather than following marketing.
What are 5 supplements for longevity?
Commonly discussed options include vitamin D, omega-3 fatty acids, magnesium, and the research-stage compounds NAD⁺ precursors and resveratrol. Only the first group has solid human evidence, and only for correcting deficiencies. The latter are promising but unproven in people. Test your levels and seek medical advice before starting any of them.
Do longevity supplements really work?
Some do, for narrow purposes: correcting a measured deficiency in nutrients such as vitamin D or omega-3s supports health. But no supplement is shown to slow ageing or extend lifespan in humans. Many heavily marketed “longevity” products rely on animal data alone. Treat lifespan and anti-ageing guarantees as red flags.
What are the 7 surprising nutrients you need more of as you get older?
Needs are individual, but ageing commonly raises the risk of low vitamin D, vitamin B12, calcium, magnesium, omega-3s, protein, and fibre. The word “surprising” oversells it — these are well-known gaps, not secrets. A blood test confirms which apply to you, so you supplement real deficiencies rather than guessing. Sources

Sources

  1. Cai, Y., et al. (2022). The landscape of aging. Sci China Life Sci. doi:10.1007/s11427-022-2161-3
  2. Xie, S., et al. (2023). Metabolic landscape in cardiac aging: insights into molecular biology and therapeutic implications. Signal Transduct Target Ther. doi:10.1038/s41392-023-01378-8
  3. Lautrup, S., et al. (2019). NAD⁺ in Brain Aging and Neurodegenerative Disorders. Cell Metab. doi:10.1016/j.cmet.2019.09.001
  4. Fang, E. F., et al. (2020). A research agenda for ageing in China in the 21st century (2nd edition). Ageing Res Rev. doi:10.1016/j.arr.2020.101174
  5. Grabowska, W., et al. (2017). Sirtuins, a promising target in slowing down the ageing process. Biogerontology. doi:10.1007/s10522-017-9685-9
SupplementsNMNSupplements
Aksana Labokha, PhD

Aksana Labokha, PhD

Co-founder of Lifespan Solutions and CEO of Centenara Labs, a Swiss biotechnology company developing therapies that target the hallmarks of aging. A life-science executive and venture investor with 15+ years in biotech — across AstraZeneca, Sanofi and Epidarex Capital — she holds a PhD in biochemistry from the University of Göttingen.

View profile

Explore more

Keep reading